PHARMAC's funding of 9 weeks Herceptin: many assumptions in a high-risk decision.

@inproceedings{Rj2007PHARMACsFO,
  title={PHARMAC's funding of 9 weeks Herceptin: many assumptions in a high-risk decision.},
  author={Isaacs Rj and Frampton Cm and Kuper-Hommel Mj},
  year={2007}
}